Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03734484

Gram Type Infection-Specific Sepsis Identification Using Machine Learning

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Dascena · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The focus of this study will be to conduct a prospective, randomized controlled trial (RCT) at Cape Regional Medical Center (CRMC), Oroville Hospital (OH), and UCSF Medical Center (UCSF) in which a Gram type infection-specific algorithm will be applied to EHR data for the detection of severe sepsis. For patients determined to have a high risk of severe sepsis, the algorithm will generate automated voice, telephone notification to nursing staff at CRMC, OH, and UCSF. The algorithm's performance will be measured by analysis of the primary endpoint, time to antibiotic administration. The secondary endpoint will be reduction in the administration of unnecessary antibiotics, which includes reductions in secondary antibiotics and reductions in total time on antibiotics.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTInSightThe InSight algorithm which draws information from a patient's electronic health record (EHR) to predict the onset of severe sepsis, and in this study will be customized to differentiate between various Gram-type infections.

Timeline

Start date
2022-05-01
Primary completion
2022-11-30
Completion
2023-03-01
First posted
2018-11-08
Last updated
2021-09-23

Source: ClinicalTrials.gov record NCT03734484. Inclusion in this directory is not an endorsement.